A strain of mutant mice provide a novel model for studying glucose intolerance and gestational diabetes during pregnancy and suggest that certain molecules may be useful for therapeutic applications.

Ela Knapik, associate professor of medicine, and colleagues are using zebrafish to explore the molecular and cellular mechanisms that cause birth defects of the face and skeleton.

Compounds developed at Vanderbilt could offer a whole new way to treat atherosclerosis.

A new mouse model provides a tool for testing novel therapeutic approaches for neurofibromatosis.